|
|
(ALL TALKS ON THIS PAGE ARE
AUDIO ONLY)
|
Old and new optimal PTH targets: PTH regulation of calcium metabolism and the implications for cardiovascular disease in ESRD |
Coagulation and anticoagulation in hemodialysis |
Surviving the nursing shortage |
|
Speakers
Block Geoffrey, M.D.
|
Director, Clinical Research Denver Nephrologists, Denver, Colorado |
Cantor Tom
|
President, Scatibodies Laboratory, Inc., Santee, California |
Gao Ping, M.D.
|
Director of Diagnostics, Scantibodies Laboratory, Inc., Santee, California |
Bednar Barbara
|
|
Lunn Deanna
|
Baxer Healthcare, Renal Division, National Manager, Clinical Consulting, Mississauga, Ontario, Canada |
David Green, M.D., Ph.D.
|
Professor of Medicine, Northwestern University Medical School, Chicago, Illinois |
Karl-Georg Fischer, M.D.
|
University Hospital Freiburg, Division of Nephrology, Department of Medicine, Freiburg, Germany |
Andrew Davenport, M.D., F.R.C.P.C.
|
Consultant Nephrologist and Honorary Senior Lecturer, Royal Free Hospital, Hampstead, London, United Kingdom |
|
|